Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alignment Healthcare, Inc. Director's Dealing 2023

Feb 3, 2023

31270_dirs_2023-02-03_cdb49fca-a3b7-4010-bc79-a8644d636f44.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alignment Healthcare, Inc. (ALHC)
CIK: 0001832466
Period of Report: 2023-02-01

Reporting Person: Kumar Dinesh M. (Chief Med & Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-01 Common Stock S 10000 $12.1921 Disposed 1106101 Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.41. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.